The Current Ratio as of September 2024 (TTM) for Forte Biosciences, Inc. (FBRX) is 2.82

According to Forte Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.82. This represents a change of -61.15% compared to the average of 7.26 of the last 4 quarters.

Forte Biosciences, Inc. (FBRX) Historical Current Ratio (quarterly & annually)

How has FBRX Current Ratio performed in the past?

The mean historical Current Ratio of Forte Biosciences, Inc. over the last ten years is 11.30. The current 2.82 Current Ratio has changed 2.40% with respect to the historical average. Over the past ten years (40 quarters), FBRX's Current Ratio was at its highest in in the March 2022 quarter at 32.17. The Current Ratio was at its lowest in in the March 2001 quarter at 0.

Forte Biosciences, Inc. (FBRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Forte Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Forte Biosciences, Inc. (FBRX) Average Current Ratio

How has FBRX Current Ratio performed in the past?

The current Current Ratio of Forte Biosciences, Inc. (FBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Forte Biosciences, Inc. (FBRX) Current Ratio vs. Peers

How is FBRX’s Current Ratio compared to its peers?

Forte Biosciences, Inc.’s Current Ratio is less than Indaptus Therapeutics, Inc. (3.88), less than Rezolute, Inc. (11.82), greater than Tempest Therapeutics, Inc. (2.17), greater than Comera Life Sciences Holdings, Inc. (0.90), greater than ABVC BioPharma, Inc. (0.33), less than Pasithea Therapeutics Corp. (6.20), greater than Better Therapeutics, Inc. (0.57), greater than ZIVO Bioscience, Inc. (0.17), less than Theseus Pharmaceuticals, Inc. (29.93), less than Erasca, Inc. (16.79), less than Applied Molecular Transport Inc. (4.99), less than Werewolf Therapeutics, Inc. (12.13), less than Edgewise Therapeutics, Inc. (30.24), less than Decibel Therapeutics, Inc. (3.03), less than Celcuity Inc. (14.95), less than C4 Therapeutics, Inc. (5.09),

Build a custom stock screener for Forte Biosciences, Inc. (FBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forte Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Forte Biosciences, Inc. (FBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Forte Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.